Manuscript Objectives:

• Review the challenges and opportunities for SC delivery of high dose/volume biologics
• Consider the potential to apply novel SC technologies to several therapeutic areas through collaborations across industry and academia
• Summarize key patient and HCP perceptions of high dose/volume SC delivery
• Highlight developing SC technologies that could further facilitate high dose/volume SC administration, as informed by a literature review and search